Additional information
| Capsule Size | 500mcg/500mcg 90ct capsules |
|---|
ADD $500 MORE FOR FREE SHIPPING YOU HAVE UNLOCKED FREE SHIPPING
$358.50
This fixed-combination formulation pairs BPC-157, a synthetic pentadecapeptide studied in angiogenic receptor and extracellular-matrix models, with KPV, the C-terminal tripeptide of α-MSH studied in NF-κB- and MAPK-linked inflammatory signaling. Combining both in one capsule supports assay designs that examine matrix-associated and inflammatory pathways in parallel within the same model system. Supplied at 500 mcg of each peptide per capsule, 90 capsules per container, with a batch-specific Certificate of Analysis for use in controlled in-vitro investigation only.
Become a Member and save 20% on every order.
Become a Member| Capsule Size | 500mcg/500mcg 90ct capsules |
|---|
All products sold by Stackhaus Research are intended exclusively for in vitro laboratory research purposes. These products are not approved for, and may not be used in, diagnostic, therapeutic, or clinical procedures, or for administration to humans or animals under any circumstances.
Stackhaus Research does not claim that any product has been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any equivalent regulatory authority. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
The buyer assumes full responsibility for the safe handling, storage, and lawful use of this product. Stackhaus Research, LLC is not liable for any direct or indirect damages resulting from improper handling, storage, or unauthorized use. Stackhaus Research reserves the right to refuse sales to any individual or entity suspected of misuse. By completing your purchase, you agree to these terms.